Example: air traffic controller
Naproxen 250mg, 375mg and 500mg Gastro-resistant tablets
• ciclosporin or tacrolimus • mifepristone – do not take NSAIDs 8-12 days after mifepristone • SSRI antidepressants • zidovudine • quinolones (e.g. ciprofloxacin) • probenecid • methotrexate • antacids • bisphosphonates • colestyramine (take naproxen 1 hour before or 4 to 6 hours after colestyramine to avoid
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
Related documents
HIGHLIGHTS OF PRESCRIBING INFORMATION NOXAFIL. …
www.merck.comcyclosporine or tacrolimus; reduce dose of cyclosporine and tacrolimus and monitor concentrations frequently. (5.1) Arrhythmias and QTc Prolongation: Noxafil has been shown to prolong the QTc interval and cause cases of TdP. Administer with caution to patients with potentially proarrhythmic conditions. Do not
LIST OF MEDICATIONS THAT MAY STAIN OR DAMAGE …
www.prosthetics.va.govtacrolimus 0.03% top oint no. tacrolimus 0.1% top oint no. tazarotene 0.1% top gel no. terbinafine hcl 1% cream no. tetracaine hcl col 2% no. tetracycline ointment yes . tetracycline oral (250mg, 500mg caps) no. tinc of benzoin spray (cn) no. toluidine blue no . blue urine discoloration
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euproducts (e.g., azathioprine, tacrolimus, ciclosporin) are limited and caution should be exercised when using such combinations (see section 4.5). In atopic dermatitis, combination with ciclosporin or other potent immunosuppressants has not been studied and is not recommended (see section 4.5). Hypersensitivity
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euCombination with other potent immunosuppressants such as azathioprine, ciclosporin, tacrolimus, and biologic DMARDs or other Janus kinase (JAK) inhibitors has not been evaluated in clinical studies and is not recommended as a risk of additive immunosuppression cannot be excluded. Serious infections
Laboratory Specimen Tube Type Collection Chart
www.saskatoonhealthregion.caTacrolimus Lavender EDTA *BLU* *R10* *SST* *PST* *GPT* *GNH* *K2E* *LAV* Use 2.7 mL Citrate Pediatric Use ONLY 1.8 mL Clear Citrate BLU …